匯達工商鋪基金目標未來3至5年集資規模達5億元
現代健康科技(00919.HK)全資附屬匯達基金管理獲委任為匯達工商鋪基金之基金管理人及投資管理,容許專業投資者以低門檻投資工商鋪物業,目標未來3至5年集資規模達5億元。
現代健康科技控股主席曾裕表示,基金現時集資規模達數千萬元,首階段計劃買入3物業舖位,分別位於中環、銅鑼灣、旺角,每間涉資約2,000至3,000萬元,為小型商業吉舖。
現代健康科技首席財務總監兼匯達基金管理副總裁鄭志明指,匯達基金管理下一步會繼續物色管理針對其他地區市場包括但不限於大灣區、新加坡等具備零售性質的工商物業買賣投資的基金機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.